Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Hedge Funds Think About Mindray Medical International Ltd (ADR) (MR)

Page 1 of 2

In the 21st century investor’s toolkit, there are tons of gauges investors can use to track stocks. A pair of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the top investment managers can trounce the market by a healthy amount (see just how much).

Equally as useful, positive insider trading sentiment is a second way to look at the financial markets. Just as you’d expect, there are a variety of incentives for a bullish insider to downsize shares of his or her company, but just one, very clear reason why they would behave bullishly. Several academic studies have demonstrated the market-beating potential of this method if you know what to do (learn more here).

What’s more, it’s important to discuss the recent info surrounding Mindray Medical International Ltd (ADR) (NYSE:MR).

Hedge fund activity in Mindray Medical International Ltd (ADR) (NYSE:MR)

Heading into Q3, a total of 11 of the hedge funds we track held long positions in this stock, a change of 0% from the previous quarter. With the smart money’s positions undergoing their usual ebb and flow, there exists a few noteworthy hedge fund managers who were upping their holdings meaningfully.

Mindray Medical International Ltd (ADR) (NYSE:MR)When using filings from the hedgies we track, Joho Capital, managed by Robert Karr, holds the biggest position in Mindray Medical International Ltd (ADR) (NYSE:MR). Joho Capital has a $84.2 million position in the stock, comprising 7.2% of its 13F portfolio. The second largest stake is held by Platinum Asset Management, managed by Kerr Neilson, which held a $23.3 million position; 0.4% of its 13F portfolio is allocated to the company. Some other hedgies with similar optimism include Jim Simons’s Renaissance Technologies, J. Alan Reid Jr.’s Forward Management and David Blood and Al Gore’s Generation Investment Management.

Because Mindray Medical International Ltd (ADR) (NYSE:MR) has experienced bearish sentiment from the entirety of the hedge funds we track, it’s easy to see that there is a sect of funds that slashed their positions entirely heading into Q2. It’s worth mentioning that William B. Gray’s Orbis Investment Management said goodbye to the largest investment of all the hedgies we monitor, worth an estimated $86.9 million in stock, and D. E. Shaw of D E Shaw was right behind this move, as the fund sold off about $1.1 million worth. These moves are important to note, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

What have insiders been doing with Mindray Medical International Ltd (ADR) (NYSE:MR)?

Legal insider trading, particularly when it’s bullish, is best served when the primary stock in question has seen transactions within the past six months. Over the latest 180-day time frame, Mindray Medical International Ltd (ADR) (NYSE:MR) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to Mindray Medical International Ltd (ADR) (NYSE:MR). These stocks are C.R. Bard, Inc. (NYSE:BCR), CareFusion Corporation (NYSE:CFN), Teleflex Incorporated (NYSE:TFX), DENTSPLY International Inc. (NASDAQ:XRAY), and The Cooper Companies, Inc. (NYSE:COO). All of these stocks are in the medical instruments & supplies industry and their market caps match MR’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!